Angiodynamics (ANGO) Income from Continuing Operations (2010 - 2026)
Angiodynamics' (ANGO) quarterly Income from Continuing Operations came in at 11405000.0 in Q2 2026, down 88.51% YoY from 99280935.25 in Q2 2025, and down 41.08% on a QoQ basis from 8084000.0 in Q1 2026.
Angiodynamics (ANGO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Income from Continuing Operations data on file, last reported at 11405000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 88.51% year-over-year to 11405000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was 36742000.0 (down 8.09% YoY) and the FY2026 annual result came in at 36742000.0, down 8.09% from the prior year.
- Income from Continuing Operations slipped to 11405000.0 in Q2 2026, from 8084000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 45884000.0 in Q3 2023 to a low of 187736000.0 in Q1 2024.
- A 5-year average of 17708333.33 and a median of 10111500.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 452.85% — and 2024, when it slumped 1879.29%.
- Tracing ANGO's Income from Continuing Operations over 5 years: stood at 8486000.0 in 2022, then slumped by 242.3% to 29048000.0 in 2023, then jumped by 63.03% to 10738000.0 in 2024, then soared by 40.86% to 6350000.0 in 2025, then plunged by 79.61% to 11405000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 11405000.0 (Q2 2026), 8084000.0 (Q1 2026), and 6350000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | -11.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -11.41 Mn |
| Feb 28, 2026 | -8.08 Mn |
| Nov 30, 2025 | -6.35 Mn |
| Aug 31, 2025 | -10.90 Mn |
| May 31, 2025 | -6.05 Mn |
| Feb 28, 2025 | -4.41 Mn |
| Nov 30, 2024 | -10.74 Mn |
| Aug 31, 2024 | -12.80 Mn |
| May 31, 2024 | -13.45 Mn |
| Feb 29, 2024 | -187.74 Mn |
| Nov 30, 2023 | -29.05 Mn |
| Aug 31, 2023 | 45.88 Mn |
| May 31, 2023 | -21.47 Mn |
| Feb 28, 2023 | -9.49 Mn |
| Nov 30, 2022 | -8.49 Mn |
| Aug 31, 2022 | -13.00 Mn |
| May 31, 2022 | -6.27 Mn |
| Feb 28, 2022 | -4.96 Mn |
| Nov 30, 2021 | -8.35 Mn |
| Aug 31, 2021 | -6.97 Mn |